Back to results
US 11,028,083 B2Granted
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
AssigneeBoard of Regents, The University of Texas System
InventorsMaria Emilia Di Francesco, Philip Jones, Timothy Joseph McAfoos
Life of this patent
Estimating the term…
Abstract
The present invention relates to ethanediamine-heterocycle compounds that are able to act as inhibitors of PRMTs (protein arginine methyltransferases) for treating cancer and other diseases mediated by PRMTs.
Claims36
A compound of structural Formula I
- or a salt thereof, wherein:
- A is a monocyclic heterocycloalkyl ring comprising 5 to 7 ring members including:
- X1 and X2,
- Z, which is chosen from —CH2—, —CHR3—, —C(R3)2—, —N(R5a)—, N(COR5a)—,
- N(CONR5aR5b)—, N(SO2R5a)—, —O—, and —SO2—, and
- all other ring members Y, which are chosen from —CH2—, —CHR2—, and —C(R2)2—;
- R1a, R1b, and R1c are independently chosen from H and CH3;
- either X1 is C and X2 is N, or X1 is N and X2 is C;
- each R2 and R3 is independently chosen from cyano, halo, hydroxy, C1-6alkyl,
- C1-6haloalkyl, C1-6hydroxyalkyl, (C1-6alkoxy)C1-6 alkyl;
- OR5a, C(O)R5a, C(O)OR5a, C(O)NR5aR5b, SO2R5a;
- SO2NR5aR5b, NR5aR5b, NR5aC(O)R5b, NR5cC(O)OR5b, NR5cC(O)NR5aR5b, and NR5aSO2R5b, or
- any two R2 or R3, when directly attached to the same atom, forms a 3-7 membered cycloalkyl or heterocycloalkyl ring;
- R4 is chosen from cycloalkyl, heterocycloalkyl, aryl and heteroaryl, any of which is optionally substituted with 1, 2, 3, or 4 R6 groups;
- each R5a and R5b is independently chosen from H, C1-6alkyl, cyanoC1-6alkyl, haloC1-6alkyl, hydroxyC1-6alkyl, (C1-6alkoxy)C1-6 alkyl;
- C3-6 cycloalkyl, cyanoC3-6 cycloalkyl, haloC3-6 cycloalkyl, hydroxyC3-6 cycloalkyl, and (C3-6 alkoxy)C3-6 cycloalkyl, or
- R5a and R5b, when directly attached to the same atom, forms a 3-7 membered cycloalkyl or heterocycloalkyl ring;
- R5c is chosen from H, C1-6alkyl, cyanoC1-6alkyl, haloC1-6alkyl, hydroxyC1-6alkyl, (C1-6 alkoxy)C1-6 alkyl;
- C3-6 cycloalkyl, cyanoC3-6 cycloalkyl, haloC3-6 cycloalkyl, hydroxyC3-6 cycloalkyl, and (C3-6 alkoxy)C3-6 cycloalkyl;
- each R6 is independently chosen from C1-6alkyl, cyanoC1-6alkyl, haloC1-6alkyl, hydroxyC1-6alkyl, (C1-6 alkoxy)C1-6 alkyl, (haloC1-6alkoxy)C1-6alkyl, C3-6 cycloalkyl, cyanoC3-6 cycloalkyl, haloC3-6 cycloalkyl, hydroxyC3-6 cycloalkyl, (C3-6 alkoxy)C3-6 cycloalkyl, (C3-6 cycloalkyl)C1-6alkyl, (heterocycloalkyl)C1-6alkyl, (aryl)C1-6alkyl, (heteroaryl)C1-6alkyl, ((C1-6alkyl)aryl)C1-6alkyl, ((C1-6alkyl)heteroaryl)C1-6alkyl, OR7, CH2OR7, CH2CH2OR7, COR7, COOH, COOR7, CONH2, CONHR7, CON(R7)2, NHCOR7, NR7COR7, NHCONH2, NHCONHR7, NHCON(R7)2, NR7CONH2, NR7CONHR7, NR7CON(R7)2, SO2R7, SO2NHR7, SO2N(R7)2, NHSO2R7, NR7SO2R7, carboxy, cyano, halo, hydroxy, and oxo;
- each R7 is independently chosen from C1-6alkyl, haloC1-6alkyl, aryl, heteroaryl, C3-6cycloalkyl, heterocycloalkyl, (aryl)C1-6alkyl, (heteroaryl)C1-6 alkyl, (cycloalkyl)C1-6alkyl, and (heterocycloalkyl)C1-6 alkyl, any of which is optionally substituted with 1 or 2 R8 groups;
- and
- each R8 is independently chosen from C1-6 alkyl, haloC1-6 alkyl, C3-6 cycloalkyl, and haloC3-6 cycloalkyl.
20 more elements
A compound chosen from:
Dependencies are inferred from the claim text.